anim
model
invalu
studi
viral
replic
vivo
pathogenesi
viral
infect
host
immun
respons
efficaci
antivir
intervent
despit
util
anim
model
constrain
inabl
monitor
viral
replic
dynam
real
time
cohort
anim
infect
euthan
viral
load
immun
respons
measur
predetermin
tissu
produc
static
snapshot
replic
specif
time
specif
site
within
anim
moreov
inher
animaltoanim
variabl
introduc
signific
confound
effect
result
studi
requir
hundr
anim
acquir
statist
signific
power
tradit
approach
complement
mani
limit
overcom
use
vivo
bioluminesc
imag
bli
fig
bli
detect
light
produc
luciferas
enzym
grow
list
virus
engin
express
luciferas
exploit
technolog
tabl
enabl
rapid
measur
viral
load
time
ie
longitudin
measur
tissu
distribut
interhost
transmiss
impact
therapeut
treatment
anim
model
luciferas
enzym
oxid
substrat
produc
light
co
luciferas
broadli
classifi
substrat
firefli
fluc
beetl
luciferas
oxid
dluciferin
wherea
renilla
luciferas
rluc
gaussia
luciferas
gluc
nanoluc
nluc
oxid
coelenterazin
analogu
tabl
larg
dynam
rang
luciferas
reaction
absenc
endogen
luciferas
activ
use
chargecoupl
devic
ccd
camera
result
specif
exquisit
sensit
noninvas
detect
bioluminesc
techniqu
use
great
success
studi
viral
infect
vivo
bli
viral
infect
requir
product
recombin
virus
encod
luciferas
report
virus
use
infect
anim
result
luciferas
express
infect
cell
substrat
inject
anim
bioluminesc
infect
cell
measur
wholebodi
imag
light
output
quantifi
data
overlaid
onto
anim
provid
spatial
resolut
viral
load
noninvas
natur
techniqu
permit
longitudin
measur
anim
key
advantag
dramat
reduc
animaltoanim
variabl
sheer
number
anim
requir
experi
furthermor
bli
measur
light
output
viral
load
diseas
progress
monitor
absenc
overt
sign
pathogenesi
mani
human
viral
infect
lethal
use
bli
measur
replic
efficaci
antivir
treatment
subleth
vaccinia
viru
orthopoxvirus
sendai
viru
nipah
viru
respiratori
syncyti
viru
mous
hepat
coronaviru
murin
gammaherpesviru
dengu
viru
coelenterazin
small
enzym
size
nanoluc
engin
luciferas
origin
deriv
deep
sea
shrimp
oplophoru
gracilirostri
nanoluc
optim
use
furimazin
substrat
also
engin
coelenterazin
analogu
infect
close
mimic
cours
diseas
human
may
faith
recapitul
therapeut
benefit
antivir
treatment
almost
luciferasesubstr
pair
use
track
viral
infect
vivo
possess
uniqu
advantag
depend
viru
desir
imag
outcom
tabl
fluc
commonli
use
given
rel
eas
imag
longliv
signal
due
glowtyp
kinet
low
cost
favor
emiss
properti
substrat
administ
via
intraperiton
rout
peak
bioluminesc
occur
min
inject
persist
signal
remain
min
overli
tissu
biolog
molecul
absorb
scatter
light
attenu
signal
visibl
light
emiss
per
centimet
overli
tissu
becom
pronounc
shorter
wavelength
longer
peak
emiss
wavelength
fluc
nm
contribut
high
level
sensit
vivo
imag
major
limit
fluc
larg
size
kda
mani
viral
genom
toler
larg
insert
viru
sever
attenu
singlecycl
particular
concern
compact
genom
mani
rna
virus
luciferas
oxid
coelenterazin
derivativesrluc
gluc
nlucar
much
smaller
kda
avoid
primari
limit
fluc
tabl
small
genom
space
requir
encod
gluc
nluc
key
featur
develop
influenza
report
virus
suitabl
bli
unfortun
rluc
gluc
nluc
emit
blueshift
light
significantli
absorb
scatter
overli
tissu
limit
blueshift
light
output
pronounc
deeper
tissu
significantli
limit
sensit
luciferas
sensit
gluc
rluc
reduc
flashtyp
kinet
substrat
must
administ
intraven
mous
less
half
origin
gluc
signal
remain
inject
bioluminesc
return
background
within
min
concern
partial
minim
nluc
exhibit
glowtyp
kinet
extrem
bright
signal
specif
higher
either
fluc
rluc
result
highli
sensit
bli
despit
shorter
emiss
wavelength
nluc
gluc
also
stabl
enzym
increas
sensit
purifi
protein
although
stabil
must
consid
luciferas
activ
may
persist
viral
gene
express
ceas
notwithstand
limit
luciferas
instrument
develop
virus
bli
fluc
suitabl
multiplex
exist
fluc
report
system
queri
multipl
variabl
contrast
mani
vivo
system
requir
sacrific
anim
noninvas
bli
yield
realtim
temporospati
data
track
time
anim
fig
exemplifi
studi
vaccinia
viru
express
fluc
bli
report
viral
load
tissu
distribut
mice
bli
infect
knockout
mice
highlight
import
role
interferon
respons
control
infect
analysi
longitudin
measur
reveal
biolumines
signal
intens
earli
strong
predictor
lethal
mice
bli
quickli
detect
reduct
replic
due
vaccin
passiv
immun
bli
use
number
virus
test
activ
antivir
drug
fig
vaccin
neutral
antibodi
lower
number
anim
need
speed
data
acquisit
bli
potenti
rapidli
acceler
identif
antivir
compound
effect
inhibit
replic
vivo
test
efficaci
exist
antivir
newli
emerg
virus
strain
depth
data
acquir
bli
move
beyond
simpli
determin
viral
load
add
inform
viru
replic
host
way
feasibl
tradit
endpoint
experi
anim
wholebodi
imag
routin
use
identifi
unexpect
site
replic
would
miss
target
approach
instanc
detect
influenza
viru
replic
conjunctiva
andor
eye
infect
ferret
detect
murin
gammaherpesviru
replic
salivari
gland
infect
mous
area
would
normal
sampl
longitudin
measur
reveal
dynam
viru
replic
within
anim
infect
track
one
site
next
fig
case
show
discret
kinet
establish
infect
differ
tissu
type
compart
anim
anim
via
contact
aerosol
transmiss
combin
tempor
spatial
data
transmiss
studiesdata
acquir
bliit
reveal
qualiti
immun
protect
reinfect
depend
prior
infect
also
site
anim
prior
infect
occur
vivo
bli
power
techniqu
sever
limit
must
consid
acquir
reproduc
repres
data
includ
product
suitabl
report
viru
imag
techniqu
ideal
report
virus
phenocopi
parent
viru
princip
replic
kinet
pathogen
report
virus
optim
degre
choic
luciferas
reduct
pathogen
overcom
use
higher
dose
viru
adapt
report
virus
anim
critic
luciferas
report
stabli
maintain
viru
essenti
abl
detect
site
replic
prevent
outgrowth
silent
virus
lack
report
gene
final
note
bli
report
viru
gene
express
necessarili
mean
replic
caveat
especi
true
virus
high
particl
pfu
ratio
light
output
come
product
infect
cell
well
support
replic
still
express
viral
encod
report
concern
minim
experi
correl
bli
signal
intens
classic
measur
viral
titer
mechan
imag
also
influenc
result
data
rout
substrat
administr
time
inject
imag
must
optim
enzym
experiment
system
repeat
precis
acquir
reproduc
data
nluc
rluc
gluc
requir
intraven
inject
substrat
limit
throughput
imag
anim
posit
must
also
optim
account
coat
color
skin
pigment
depth
emit
site
overli
tissu
tissu
type
absorb
equal
given
reduc
signal
attenu
longer
wavelength
light
fluc
prefer
imag
viral
infect
deeper
site
follow
substrat
administr
bioluminesc
imag
complet
within
minut
significantli
faster
imag
modal
report
viru
imag
techniqu
optim
vivo
bioluminesc
must
correl
classic
measur
viral
load
establish
sensit
system
determin
whether
light
output
quantit
report
site
replic
viral
titer
addit
immedi
applic
viral
bli
studi
viral
dynam
fig
sever
excit
extens
bli
potenti
simultan
queri
multipl
variabl
substrat
specif
luciferas
permit
dual
luciferas
assay
measur
two
distinct
variabl
instanc
virus
encod
differ
luciferas
monitor
anim
use
newli
develop
luciferin
distinct
emiss
profil
delin
activ
differ
enzym
sever
new
substrat
redshift
emiss
spectra
dramat
increas
detect
sensit
deep
tissu
site
multiplex
could
use
track
individu
clone
within
popul
growth
two
differ
virus
mix
infect
strategi
appli
studi
secondari
bacteri
infect
use
bacteria
express
lux
operon
bioluminesc
bacteria
pair
report
virus
could
establish
interplay
viru
bacteria
cumul
contribut
morbid
mortal
infect
host
respons
infect
monitor
multiplex
bli
transgen
report
mice
develop
express
fluc
respons
immun
stimul
sequenti
imag
gluc
nluc
report
viru
follow
fluc
host
report
could
correl
viral
load
host
immun
respons
multimod
imag
bli
petct
fluoresc
imag
also
measur
host
respons
simultan
quantifi
viral
load
bli
inflamm
petct
fig
similar
approach
use
bli
pair
fluoresc
imag
use
fluoresc
probe
detect
multipl
aspect
immun
respons
newer
technolog
provid
even
richer
dataset
virushost
interact
cage
luciferin
activat
probe
must
cleav
suitabl
substrat
cage
luciferin
report
specif
biolog
process
includ
proteas
reactiv
oxygen
speci
produc
bacteri
infect
exampl
luciferin
coval
modifi
amino
acid
repres
caspas
cleavag
site
devdluciferin
activ
caspas
cleavag
result
light
output
report
level
apoptosi
luciferas
suppli
system
result
preferenti
light
emiss
site
activ
one
envis
virusspecif
cage
luciferin
activ
viral
proteas
neuraminidas
luciferas
express
anim
cage
luciferin
activ
viral
enzym
infect
cell
would
obviat
need
product
special
report
virus
allow
technolog
rapidli
deploy
primari
viral
isol
split
luciferin
extend
approach
split
luciferin
system
precursor
dcystein
cyanobenzothiazol
undergo
spontan
ligat
creat
luciferin
reaction
shown
function
vivo
produc
substrat
bli
similar
cage
luciferin
split
luciferin
precursor
modifi
function
group
block
ligat
thu
must
uncag
luciferin
reconstitut
modif
precursor
result
bli
engin
report
coordin
activ
two
biolog
event
approach
might
suitabl
studi
viral
induc
apoptosi
viral
enzym
uncag
one
precursor
activ
caspas
uncag
precursor
ad
advanc
approach
exist
benefit
bli
open
new
area
studi
virushost
interfac
move
current
stopmot
snapshot
toward
dynam
understand
interplay
chang
throughout
cours
infect
respons
therapeut
treatment
